Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 6—June 2023
Research Letter

Manifestations and Management of Trimethoprim/Sulfamethoxazole–Resistant Nocardia otitidiscaviarum Infection

Katherine FuComments to Author , Kyle White, Aliaksandr Ramaniuk, Vidya Kollu, and Daniel Urbine
Author affiliation: University of Florida College of Medicine, Gainesville, Florida, USA

Main Article

Table

Sensitivity results for Nocardia otitidiscaviarum isolated from a man in Gainesville, Florida, USA, 2020

Drug Sensitivity
Amikacin Sensitive
Amoxicillin/clavulanate Resistant
Cefepime Resistant
Ceftriaxone Resistant
Ciprofloxacin Intermediate
Clarithromycin Sensitive
Doxycycline Resistant
Imipenem Intermediate
Linezolid Sensitive
Minocycline Intermediate
Moxifloxacin Sensitive
Tobramycin Intermediate
Trimethoprim/sulfamethoxazole Resistant

Main Article

Page created: April 06, 2023
Page updated: May 18, 2023
Page reviewed: May 18, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external